Page last updated: 2024-08-26

1,4-dihydropyridine and Bone Cancer

1,4-dihydropyridine has been researched along with Bone Cancer in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Alvarez, U; Duncan, R; Harter, L; Hruska, K; Kizer, N	1

Other Studies

1 other study(ies) available for 1,4-dihydropyridine and Bone Cancer

Article	Year
Volume regulatory decrease in UMR-106.01 cells is mediated by specific alpha1 subunits of L-type calcium channels. Cell biochemistry and biophysics, 1999, Volume: 31, Issue:1 Topics: Animals; Bone Neoplasms; Calcium; Calcium Channel Blockers; Calcium Channels; Calcium Channels, L-Type; Cell Size; Dihydropyridines; Hypotonic Solutions; Nifedipine; Oligonucleotides, Antisense; Osmolar Concentration; Osteoblasts; Osteosarcoma; Patch-Clamp Techniques; Protein Isoforms; Rats; Tumor Cells, Cultured	1999

Article

Year

Volume regulatory decrease in UMR-106.01 cells is mediated by specific alpha1 subunits of L-type calcium channels.

Cell biochemistry and biophysics, 1999, Volume: 31, Issue:1

Topics: Animals; Bone Neoplasms; Calcium; Calcium Channel Blockers; Calcium Channels; Calcium Channels, L-Type; Cell Size; Dihydropyridines; Hypotonic Solutions; Nifedipine; Oligonucleotides, Antisense; Osmolar Concentration; Osteoblasts; Osteosarcoma; Patch-Clamp Techniques; Protein Isoforms; Rats; Tumor Cells, Cultured

1999